AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33039390 — intervention group
Group type: EXPERIMENTAL
Intervention: Transition between success and failure
Number of subjects: 1250
Study 33039390 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality-adjusted life years
Number of subjects: 1250
Study 33039390 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic Organ Prolapse Distress Inventory and Short-Form Six-Dimension health index scores
Number of subjects: 1250
Study 33168204 — intervention group
Group type: EXPERIMENTAL
Intervention: Classroom-based intervention targeting self-regulation and healthy food liking through mindfulness and games
Number of subjects: 39
Study 33168204 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 39
Study 36163989 — intervention group
Group type: EXPERIMENTAL
Intervention: PAC 200mg BID
Number of subjects: 308
Study 36163989 — intervention group
Group type: EXPERIMENTAL
Intervention: PAC 400mg QD
Number of subjects: 308
Study 36163989 — intervention group
Group type: COMPARATOR
Intervention: BAT
Number of subjects: 308
Study 34798867 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-based radiomics signature for well-differentiated TSCC
Number of subjects: 127
Study 34798867 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-based radiomics signature for poorly differentiated TSCC
Number of subjects: 127
Study 34340170 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 100
Study 34340170 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 100
Study 34028358 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (14 weeks, therapist-guided)
Number of subjects: 239
Study 34028358 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 239
Study 32985230 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver Speaks intervention (photo‐elicitation storytelling via a privately facilitated Facebook group)
Number of subjects: 468
Study 32985230 — intervention group
Group type: COMPARATOR
Intervention: Usual hospice care (control group)
Number of subjects: 468
Study 32985230 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver Speaks intervention
Number of subjects: 468
Study 32073956 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib 300 mg twice a day
Number of subjects: 266
Study 32073956 — intervention group
Group type: COMPARATOR
Intervention: Nonplatinum chemotherapy (physician's choice: pegylated liposomal doxorubicin, paclitaxel, gemcitabine, or topotecan)
Number of subjects: 266
Study 32073956 — intervention group
Group type: COMPARATOR
Intervention: Nonplatinum chemotherapy (physician's choice)
Number of subjects: 266
Study 33754375 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) 75 to 300mg
Number of subjects: 33
Study 33754375 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 33754375 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) 300mg
Number of subjects: 33
Study 32338459 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg generic dabigatran etexilate capsule (test drug)
Number of subjects: 0
Study 32338459 — intervention group
Group type: COMPARATOR
Intervention: Commercial dabigatran etexilate capsule (Pradaxa® , reference drug)
Number of subjects: 0
Study 32338459 — intervention group
Group type: EXPERIMENTAL
Intervention: Both test and reference drugs
Number of subjects: 0
Study 34820856 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive transfusion strategy
Number of subjects: 637
Study 34820856 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukoreduced RBC transfusions
Number of subjects: 637
Study 34820856 — intervention group
Group type: EXPERIMENTAL
Intervention: >20 cc/kg volume of leukoreduced RBC transfusions
Number of subjects: 637
Study 34820856 — intervention group
Group type: EXPERIMENTAL
Intervention: ≥3 leukoreduced RBC transfusions
Number of subjects: 637
Study 33637477 — intervention group
Group type: EXPERIMENTAL
Intervention: MSPEs for Black and Hispanic/Latinx applicants
Number of subjects: 339
Study 33637477 — intervention group
Group type: EXPERIMENTAL
Intervention: MSPEs overall
Number of subjects: 339
Study 32020863 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care education intervention
Number of subjects: 91
Study 32020863 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 91
Study 35617320 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower limbs (LL) endurance training program for 18 sessions (3 sessions/week for 6 weeks)
Number of subjects: 31
Study 35617320 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper limbs, lower limbs, and breathing exercises (ULB) program for 18 sessions (3 sessions/week for 6 weeks)
Number of subjects: 31
Study 35617320 — intervention group
Group type: COMPARATOR
Intervention: Control group (11 patients who refused to participate in the ET program)
Number of subjects: 31
Study 34174914 — intervention group
Group type: EXPERIMENTAL
Intervention: HD-tDCS at 1.5 mA
Number of subjects: 60
Study 34174914 — intervention group
Group type: EXPERIMENTAL
Intervention: HD-tDCS at 2 mA
Number of subjects: 60
Study 34174914 — intervention group
Group type: COMPARATOR
Intervention: Sham HD-tDCS
Number of subjects: 60
Study 34174914 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60
Study 34848312 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion (1 µg.kg‐1 loading, 0.6 µg.kg‐1.h‐1 infusion)
Number of subjects: 96
Study 34848312 — intervention group
Group type: EXPERIMENTAL
Intervention: Lignocaine-dexmedetomidine infusion (1.5 mg.kg‐1 loading, 2 mg.kg‐1.h‐1 infusion and 1 µg.kg‐1 loading, 0.5 µg.kg‐1.h‐1 infusion)
Number of subjects: 96
Study 34848312 — intervention group
Group type: COMPARATOR
Intervention: Lignocaine infusion (1.5 mg.kg‐1 loading, 2 mg.kg‐1.h‐1 infusion)
Number of subjects: 96
Study 34848312 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (10 mL loading, 1 mL.kg‐1.h‐1 infusion)
Number of subjects: 96
Study 32576496 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib
Number of subjects: 78
Study 32576496 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 32675432 — intervention group
Group type: EXPERIMENTAL
Intervention: Tomographic neurofeedback (TONF)
Number of subjects: 48
Study 32675432 — intervention group
Group type: COMPARATOR
Intervention: Traditional electrode-based neurofeedback (NTNF)
Number of subjects: 48
Study 32675432 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (TONF and NTNF)
Number of subjects: 48
Study 36080405 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid crystalline oligomers polymerized in freely suspended aqueous media
Number of subjects: 0
Study 36080405 — intervention group
Group type: EXPERIMENTAL
Intervention: Reactive liquid crystalline monomers oligomerized in a micro-channel
Number of subjects: 0
Study 36080405 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-confinement in a top-down microfabricated mold
Number of subjects: 0
Study 34567960 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-weekly BTA treatment
Number of subjects: 263
Study 34567960 — intervention group
Group type: COMPARATOR
Intervention: 12-weekly BTA treatment
Number of subjects: 263
Study 33171597 — intervention group
Group type: EXPERIMENTAL
Intervention: Korean Red Ginseng (2 g once daily)
Number of subjects: 68
Study 33171597 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 g once daily)
Number of subjects: 68
Study 34841995 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic hamstring and sprint exercises (EG)
Number of subjects: 49
Study 34841995 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 49
Study 34086485 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-facilitated self-management support with weekly automated interactive voice response telephone calls for 12 months
Number of subjects: 204
Study 34086485 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-facilitated self-management support
Number of subjects: 204
Study 34086485 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care with printed generic self-management instructions
Number of subjects: 204
Study 35316144 — intervention group
Group type: EXPERIMENTAL
Intervention: New heat and moisture exchangers (HMEs) and adhesives
Number of subjects: 40
Study 35316144 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 40
Study 32993326 — intervention group
Group type: EXPERIMENTAL
Intervention: Woodcast (WCG)
Number of subjects: 170
Study 32993326 — intervention group
Group type: COMPARATOR
Intervention: Dynacast (DNG)
Number of subjects: 170
Study 33546885 — intervention group
Group type: EXPERIMENTAL
Intervention: CyclAGel 0.05%/QD
Number of subjects: 240
Study 33546885 — intervention group
Group type: EXPERIMENTAL
Intervention: CyclAGel 0.05%/BID
Number of subjects: 240
Study 33546885 — intervention group
Group type: EXPERIMENTAL
Intervention: CyclAGel 0.1%/QD
Number of subjects: 240
Study 33546885 — intervention group
Group type: COMPARATOR
Intervention: Restasis 0.05%/BID
Number of subjects: 240
Study 36228432 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33430808 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin/gemcitabine (2 cycles)
Number of subjects: 52
Study 33430808 — intervention group
Group type: COMPARATOR
Intervention: Control group (breast surgery without carboplatin/gemcitabine)
Number of subjects: 52
Study 33430808 — intervention group
Group type: EXPERIMENTAL
Intervention: Total study population
Number of subjects: 52
Study 33186309 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-Initiated-Programme-to-Prepare-for-Operation (HIPPO) including an animated video and activity sheets
Number of subjects: 130
Study 33186309 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-Initiated-Programme-to-Prepare-for-Operation (HIPPO)
Number of subjects: 130
Study 33186309 — intervention group
Group type: COMPARATOR
Intervention: Standard pre-operative workflow (Control)
Number of subjects: 130
Study 33121507 — intervention group
Group type: EXPERIMENTAL
Intervention: Rad-score (radiomics signature)
Number of subjects: 226
Study 33121507 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram model incorporating Rad-score and clinical staging
Number of subjects: 226
Study 33121507 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram model
Number of subjects: 226
Study 35428364 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid chest compression technique
Number of subjects: 0
Study 35428364 — intervention group
Group type: COMPARATOR
Intervention: Passive hallux mobilization (Control)
Number of subjects: 0
Study 34001024 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambient bright light treatment (1000 lx, 6000 K from 10:00 to 15:00)
Number of subjects: 69
Study 34001024 — intervention group
Group type: COMPARATOR
Intervention: Placebo condition (continuous standard light levels 150-300 lx, 3000 K)
Number of subjects: 69
Study 32787848 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginally administered conjugated estrogens tablet (0.625 mg, daily for 3 weeks then twice weekly for 9 weeks)
Number of subjects: 67
Study 32787848 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study 33735517 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback relaxation (BR) during LA administration
Number of subjects: 70
Study 33735517 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio-visual (AV) distraction during LA administration
Number of subjects: 70
Study 33735517 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (BR and AV)
Number of subjects: 70
Study 33735517 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback relaxation (BR)
Number of subjects: 70
Study 33735517 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio-visual (AV) distraction (AV)
Number of subjects: 70
Study 35084038 — intervention group
Group type: EXPERIMENTAL
Intervention: Mat Pilates (MP)
Number of subjects: 60
Study 35084038 — intervention group
Group type: EXPERIMENTAL
Intervention: Mat Pilates plus Aerobic Exercise (MP + AE)
Number of subjects: 60
Study 35084038 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 60
Study 33620880 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative-pressure isolation mask during gastroscopy
Number of subjects: 316
Study 33620880 — intervention group
Group type: COMPARATOR
Intervention: Conventional group (no mask)
Number of subjects: 316
Study 33620880 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative-pressure isolation mask
Number of subjects: 316
Study 35787813 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-h communication skills training (CST)
Number of subjects: 90
Study 35787813 — intervention group
Group type: COMPARATOR
Intervention: Waiting list (control group)
Number of subjects: 90
Study 32115032 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose of NAM (50 mg/kg)
Number of subjects: 567
Study 32115032 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose of NAM (100 mg/kg)
Number of subjects: 567
Study 32115032 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose of BA (500 mg/kg)
Number of subjects: 567
Study 32115032 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose of BA (1,000 mg/kg)
Number of subjects: 567
Study 32115032 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound supplement (50 mg/kg NAM + 500 mg/kg BA)
Number of subjects: 567
Study 32115032 — intervention group
Group type: COMPARATOR
Intervention: High stocking density control group (HD)
Number of subjects: 567
Study 32115032 — intervention group
Group type: COMPARATOR
Intervention: Low stocking density control group (LD)
Number of subjects: 567
Study 35503488 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acustimulation (TEA)
Number of subjects: 30
Study 35503488 — intervention group
Group type: COMPARATOR
Intervention: Sham-TEA
Number of subjects: 30
Study 33577105 — intervention group
Group type: EXPERIMENTAL
Intervention: Supinated wrist position
Number of subjects: 10
Study 33577105 — intervention group
Group type: COMPARATOR
Intervention: Neutral wrist position
Number of subjects: 10
Study 32988502 — intervention group
Group type: EXPERIMENTAL
Intervention: Brown hens
Number of subjects: 576
Study 32988502 — intervention group
Group type: EXPERIMENTAL
Intervention: White hens
Number of subjects: 576
Study 32988502 — intervention group
Group type: EXPERIMENTAL
Intervention: All strains
Number of subjects: 576
Study 32988502 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper tier occupancy at night
Number of subjects: 576
Study 32988502 — intervention group
Group type: EXPERIMENTAL
Intervention: Perch occupancy
Number of subjects: 576
Study 35947362 — intervention group
Group type: EXPERIMENTAL
Intervention: Alert group (risk of 1-year mortality calculated and presented to clinicians)
Number of subjects: 3124
Study 35947362 — intervention group
Group type: COMPARATOR
Intervention: Usual-care group (no risk assessment provided)
Number of subjects: 3124
Study 34070910 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral native vitamin D3 at a dose of 2000 IU once a day for 12 months
Number of subjects: 33
Study 34070910 — intervention group
Group type: COMPARATOR
Intervention: Control group (no vitamin D supplementation)
Number of subjects: 33
Study 34925697 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC) intervention: blood pressure cuff inflated to 200 mmHg for 5 minutes, repeated four times with 5-minute perfusion between cycles.
Number of subjects: 111
Study 34925697 — intervention group
Group type: COMPARATOR
Intervention: Sham intervention: blood pressure cuff inflated to 20 mmHg, performed similarly to RIPC.
Number of subjects: 111
Study 34925697 — intervention group
Group type: EXPERIMENTAL
Intervention: RIPC
Number of subjects: 111
Study 34925697 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 111
Study 32289824 — intervention group
Group type: EXPERIMENTAL
Intervention: Olfactory training with four odors (rose, vanilla, chocolate, peach) every two hours for four weeks
Number of subjects: 42
Study 32289824 — intervention group
Group type: COMPARATOR
Intervention: No olfactory training (control group)
Number of subjects: 42
Study 34801470 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentrated Growth Factor Fibrin (CGF)
Number of subjects: 118
Study 34801470 — intervention group
Group type: COMPARATOR
Intervention: Control (serum)
Number of subjects: 118
Study 616769489 — intervention group
Group type: EXPERIMENTAL
Intervention: Quiet atmosphere during SCT assessment
Number of subjects: 42
Study 616769489 — intervention group
Group type: COMPARATOR
Intervention: Noisy atmosphere during SCT assessment
Number of subjects: 42
Study 616769489 — intervention group
Group type: EXPERIMENTAL
Intervention: Quiet atmosphere for year 1 and 2 residents
Number of subjects: 42
Study 616769489 — intervention group
Group type: COMPARATOR
Intervention: Noisy atmosphere for year 3 and 4 residents
Number of subjects: 42
Study 34555481 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose secukinumab (75/75/150 mg)
Number of subjects: 0
Study 34555481 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose secukinumab (75/150/300 mg)
Number of subjects: 0
Study 34555481 — intervention group
Group type: COMPARATOR
Intervention: Historical placebo
Number of subjects: 0
Study 33762414 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant adjuvanted vaccine (RZV)
Number of subjects: 0
Study 33762414 — intervention group
Group type: COMPARATOR
Intervention: Live-attenuated vaccine (ZVL)
Number of subjects: 0
Study 32542650 — intervention group
Group type: EXPERIMENTAL
Intervention: Intercropping with Vulpia myuros
Number of subjects: 0
Study 32542650 — intervention group
Group type: COMPARATOR
Intervention: Black plastic film
Number of subjects: 0
Study 32542650 — intervention group
Group type: COMPARATOR
Intervention: Weed barrier fabric
Number of subjects: 0
Study 32542650 — intervention group
Group type: COMPARATOR
Intervention: Rice straw mulch
Number of subjects: 0
Study 32542650 — intervention group
Group type: COMPARATOR
Intervention: Clean tillage
Number of subjects: 0
Study 35637437 — intervention group
Group type: EXPERIMENTAL
Intervention: Head-elevated position
Number of subjects: 64
Study 34019649 — intervention group
Group type: EXPERIMENTAL
Intervention: Vergence exercises for 6 weeks
Number of subjects: 44
Study 34019649 — intervention group
Group type: COMPARATOR
Intervention: Accommodation exercises for 6 weeks
Number of subjects: 44
Study 34019649 — intervention group
Group type: EXPERIMENTAL
Intervention: Vergence exercises
Number of subjects: 44
Study 34019649 — intervention group
Group type: COMPARATOR
Intervention: Accommodation exercises
Number of subjects: 44
Study 34019649 — intervention group
Group type: EXPERIMENTAL
Intervention: Vergence exercises and Accommodation exercises
Number of subjects: 44
Study 36266099 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-energy CT (group D)
Number of subjects: 682
Study 36266099 — intervention group
Group type: COMPARATOR
Intervention: Single-energy CT (group S)
Number of subjects: 682
Study 33472477 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-segment titanium alloy posterior instrumentation (Study group)
Number of subjects: 50
Study 33472477 — intervention group
Group type: COMPARATOR
Intervention: No orthopedic surgery (Control group)
Number of subjects: 50
Study 32706681 — intervention group
Group type: EXPERIMENTAL
Intervention: Guaranteed incentive (US $10)
Number of subjects: 1517
Study 32706681 — intervention group
Group type: EXPERIMENTAL
Intervention: Lottery incentive (US $50 weekly lottery drawing)
Number of subjects: 1517
Study 32706681 — intervention group
Group type: EXPERIMENTAL
Intervention: Preferred method (guaranteed or lottery)
Number of subjects: 1517
Study 32706681 — intervention group
Group type: COMPARATOR
Intervention: Control group (no incentive mentioned)
Number of subjects: 1517
Study 32706681 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall cohort
Number of subjects: 1517
Study 35699377 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone monotherapy
Number of subjects: 485
Study 35699377 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 485
Study 35863694 — intervention group
Group type: EXPERIMENTAL
Intervention: Walk Buds walking programme
Number of subjects: 130
Study 35863694 — intervention group
Group type: COMPARATOR
Intervention: Exercise as usual
Number of subjects: 130
Study 33491811 — intervention group
Group type: EXPERIMENTAL
Intervention: iSupport online caregiver skills training and support program; n=74
Number of subjects: 151
Study 33491811 — intervention group
Group type: COMPARATOR
Intervention: Education-only e-book program; n=77
Number of subjects: 151
Study 32401873 — intervention group
Group type: EXPERIMENTAL
Intervention: Rothbaum cognitive behavioral therapy protocol (individual treatment)
Number of subjects: 70
Study 32401873 — intervention group
Group type: EXPERIMENTAL
Intervention: Rothbaum cognitive behavioral therapy protocol (group treatment)
Number of subjects: 70
Study 32401873 — intervention group
Group type: EXPERIMENTAL
Intervention: Rothbaum cognitive behavioral therapy protocol (both individual and group formats)
Number of subjects: 70
Study 35346332 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam plus temozolomide chemotherapy for 34 weeks
Number of subjects: 142
Study 35346332 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets plus temozolomide for 34 weeks
Number of subjects: 142
Study 32585438 — intervention group
Group type: EXPERIMENTAL
Intervention: In-bed cycling (30 min daily) in addition to usual-care physiotherapy
Number of subjects: 74
Study 32585438 — intervention group
Group type: COMPARATOR
Intervention: Usual-care physiotherapy
Number of subjects: 74
Study 35599463 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic manipulation of the sacroiliac joint (6 sessions)
Number of subjects: 37
Study 35599463 — intervention group
Group type: COMPARATOR
Intervention: Electrotherapy (15 sessions)
Number of subjects: 37
Study 34282232 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly myopic group
Number of subjects: 170
Study 34282232 — intervention group
Group type: COMPARATOR
Intervention: Non-highly myopic group
Number of subjects: 170
Study 35562373 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD1222 (ChAdOx1 nCoV-19)
Number of subjects: 2584
Study 35562373 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2584
Study 35799138 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 80
Study 35799138 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80